Advanced Enzyme Tech Fair Value
Advanced Enzyme Tech (ADVENZYMES) average fair value is ₹554.9 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹317.6 (+74.72%), fair value range ₹77.92–₹2028.88. For live price and a broader fundamental view, visit Advanced Enzyme Tech share price today.
Fair Value Analysis Export
ADVENZYMES Fair Value vs Current Price — Valuation Summary
ADVENZYMES average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Check Advanced Enzyme Tech market cap to track the company's total market size over time.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
ADVENZYMES Fair Value Analysis — Data Sources & Coverage
Advanced Enzyme Tech financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
ADVENZYMES vs Healthcare Sector Peers — P/E, P/B & Market Cap
Advanced Enzyme Tech P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 33.24 | 15.78 | ₹7,371 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sat Kartar Life | SATKARTAR | 13.44 | 3.4 | ₹226 |
| KRM Ayurveda | KRMAYURVED | - | 4.56 | ₹545 |
| Emcure Pharmaceuticals | EMCURE | 37.24 | 7.08 | ₹34,821 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.